BeiGene, Ltd. Quarterly Depreciation in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
BeiGene, Ltd. quarterly/annual Depreciation history and growth rate from Q1 2015 to Q3 2024.
  • BeiGene, Ltd. Depreciation for the quarter ending September 30, 2024 was $70M, a 264% increase year-over-year.
  • BeiGene, Ltd. Depreciation for the twelve months ending September 30, 2024 was $139M, a 81.1% increase year-over-year.
  • BeiGene, Ltd. annual Depreciation for 2023 was $80.4M, a 29.1% increase from 2022.
  • BeiGene, Ltd. annual Depreciation for 2022 was $62.3M, a 39.2% increase from 2021.
  • BeiGene, Ltd. annual Depreciation for 2021 was $44.7M, a 44.6% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $139M $70M +$50.8M +264% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $88M $23.8M +$2.45M +11.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $85.5M $24.1M +$5.09M +26.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $80.4M $20.9M +$3.82M +22.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $76.6M $19.2M +$4.03M +26.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $72.6M $21.3M +$6.85M +47.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $65.7M $19M +$3.45M +22.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $62.3M $17M +$4.75M +38.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $57.6M $15.2M +$3.44M +29.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $54.1M $14.5M +$3.24M +28.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $50.9M $15.6M +$6.14M +65% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $44.7M $12.3M +$4.66M +61% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $40.1M $11.8M +$3.62M +44.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $36.5M $11.2M +$3.54M +46.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $32.9M $9.44M +$1.98M +26.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $30.9M $7.64M +$488K +6.82% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $30.5M $8.16M +$4.47M +121% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $26M $7.68M +$4.32M +128% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $21.7M $7.47M +$4.38M +142% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $17.3M $7.15M +$4.44M +164% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $12.8M $3.69M +$1.48M +67.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $11.4M $3.36M +$1.26M +60.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $10.1M $3.09M +$1.1M +55.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $9M $2.71M +$1.01M +59.5% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $7.99M $2.21M +$970K +78.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $7.02M $2.1M +$1.56M +289% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $5.46M $1.98M +$1.12M +130% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $4.34M $1.7M +$1.23M +259% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $3.11M $1.24M +$732K +145% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $2.38M $540K +$48K +9.76% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $2.33M $864K +$425K +96.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $1.91M $473K +$55K +13.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $1.85M $505K +$103K +25.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $1.75M $492K +$119K +31.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $1.63M $439K +$87K +24.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $1.55M $418K Oct 1, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 $402K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $373K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 $352K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.